Company profile
Varex Imaging Corporation
NASDAQ: VREX · Healthcare · Medical - Devices
#168 of 1,422 Healthcare companies by revenue47th-percentile growth
EA Score
66BFH 65DQ 71GM 59SS 72
v0.1 · 65/100 weight · provisional
↑ filing timeliness, growth stability · ↓ 3-yr revenue growth, listing tenure
Methodology →Revenue TTM
$857.5M
Rev growth YoY (TTM)
+3.6%
Net income (FY)
-$70.3M
Employees
2,450
as of 2026-08-12
Market cap
$782.2M
as of 2026-08-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$844.6M$844.6M2025
Net income-$70.3M-$70.3M2025
Operating income-$27.8M-$27.8M2025
Total assets$1.1B$1.1B2025
Liabilities$620.8M$620.8M2025
Equity$472.6M$472.6M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY23
FY23
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2024
By product
Medical72%
Industrial28%
By geography
EMEA26%
Americas25%
Asia Pacific25%
UNITED STATES24%
The read
What is Varex Imaging Corporation’s revenue?
Varex Imaging Corporation booked $844.6M in FY2025 revenue, growing 4.1% year over year — about the middle of the pack among Healthcare companies we track, at a -8.3% net margin.
Peers · Healthcare
BioCryst Pharmaceuticals, Inc.76B+Harmony Biosciences Holdings, Inc.76B+Innovage Holding Corp.68BVerano Holdings Corp59CArrowhead Pharmaceuticals, Inc.76B+Myriad Genetics, Inc.67BNeighbors
Salt Lake →Key facts
CEOSunny S. Sanyal
SectorHealthcare
IndustryMedical - Devices
HeadquartersSalt Lake City, UT
ExchangeNASDAQ: VREX
Employees2,450
IPO date2017-01-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.